Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

National Taiwan University Hospital, Asan Medical Center, First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Chi Mei Medical Center, 81th Hospital of PLA, Korea University Medical Center, Nanfang Hospital, Jiangsu Cancer Hospital, Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Chang Gung Memorial Hospital, Academy of Military Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Southwest Hospital, Army Medical University, Dalian Medical University, First Affiliated Hospital of Dalian Medical University, Shanghai Changzheng Hospital, Kyungpook National University Hospital, Sir Run Run Shaw Hospital, Bayer (Germany), Bayer (China), Bayer (United States), Sun Yat-sen University Cancer Center